Abstract
The folate receptors (FRs) are a family of proteins coded by genes located on chromosome 11 at 11q13 telomeric to Cyclin D1. There are now four members: α, β, γ, and δ. The first two isoforms are the best studied, and they are targets for both pharmacological and immunotherapies. There is little known about the last two isoforms relative to folate homeostasis. The first two are both glycosylphosphatidylinositol-linked proteins, although soluble forms in plasma and milk also exist. FRα is overexpressed by many carcinomas. It is the most completely studied isoform, and it has been the model for receptor-mediated folate uptake by a process named “potocytosis.” To mediate folate uptake or transcytosis through epithelia, the FR appears to work in tandem with the recently described proton-coupled folate transporter (PCFT). FRβ is expressed on activated macrophages, and it is being targeted for therapy of patients with autoimmune diseases. The function of the FR, as well as regulation of its cycling in the lipid rafts on the cell membrane, is the subject of this review. The clinical significance of abnormal, missing, or soluble FR levels and associated autoantibodies will also be discussed in light of embryopathies and neurocognitive dysfunction.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Allard JE, Risinger JI, Morrison C, Young G, Rose GS, Fowler J, Berchuck A, Maxwell GL (2007) Overexpression of folate binding protein is associated with shortened progression-free survival in uterine adenocarcinomas. Gynecol Oncol 107:52–57
Antony AC, Van Horne UC, Kolhouse JF KC (1981) Isolation and characterization of a folate receptor from human placenta. J Biol Chem 256:9684–9692
Bille C, Pedersen DA, Andersen AM, Mansilla MA, Murray JC, Christensen K, Ballard JL, Gorman EB, Cabrera RM, Finnell RH (2010) Autoantibodies to folate receptor alpha during early pregnancy and risk of oral clefts in Denmark. Pediatr Res 67:274–279
Birn H, Zhai X, Holm J, Hansen SI, Jacobsen C, Christensen EI, Moestrup SK (2005) Megalin binds and mediates cellular internalization of folate binding protein. FEBS J 272:4423–4430
Cabrera RM, Shaw GM, Ballard JL, Carmichael SL, Yang W, Lammer EJ, Finnell RH (2008) Autoantibodies to folate receptor during pregnancy and neural tube defect risk. J Reprod Immunol 79:85–92
Chang WJ, Rothberg KG, Kamen BA, Anderson RWG (1992) Lowering the cholesterol content of MA104 cells inhibits receptor mediated transport of folate. J Cell Biol 118:63–69
DaCosta M, Rothenberg SP, Kamen BA (1972) DNA synthesis in chronic granulocytic leukemic cells containing unsaturated folate binder. Blood 39:621–627
Ebel W, Routhier EL, Foley B, Jacob S, McDonough JM, Patel RK, Turchin HA, Chao Q, Kline JB, Old LJ, Phillips MD, Nicolaides NC, Sass PM, Grasso L (2007) Preclinical evaluation of MORAb-003, a humanized monoclonal antibody antagonizing folate receptor-alpha. Cancer Immun 7:6
Elnakat H, Gonit M, D’Alincourt Salazar M, Zhang J, Basrur V, Gunning W, Kamen B, Ratnam M (2009) Regulation of folate receptor internalization by protein kinase C alpha. Biochemistry 48:8249–8260
Fernandes-Costa F, Metz J (1979) Role of serum folate binders in the delivery of folate to tissues and to the fetus. Br J Haematol 41:335–342
Ghitis J (1967) The folate binding in milk. Am J Clin Nutr 20:1–4
Gordon N (2009) Cerebral folate deficiency. Dev Med Child Neurol 51:180–182
Høier-Madesn M, Holm J, Hansen SI (2008) α Isoforms of soluble and membrane-linked folate-binding protein in human blood. Biosci Rep 28:153–160
Holm J, Hansen SI (2003a) Characterization of a high affinity folate binding protein in porcine serum: ionic charge, concentration-dependent polymerization and ligand binding mechanism. Biosci Rep 23:339–351
Holm J, Hansen SI (2003b) Ligand binding and polymerization characteristics of human milk folate binding protein depend on concentration of purified protein and presence of amphiphatic substances. Biosci Rep 23:77–85
Houot R, Levy R (2009) T-cell modulation combined with intratumoral CpG cures lymphoma in a mouse model without the need for chemotherapy. Blood 113:3546–3552
Houot R, Goldstein MJ, Kohrt HE, Myklebust JH, Alizadeh AA, Lin JT, Irish JM, Torchia JA, Kolstad A, Chen L, Levy R (2009) Therapeutic effect of CD137 immunomodulation in lymphoma and its enhancement by Treg depletion. Blood 14:3431–3438
Jacobson K, Mouritsen OG, Anderson RG (2007) Lipid rafts: at a crossroad between cell biology and physics. Nat Cell Biol 9:7–14
Kamen BA (2002) Folate receptor α, a review. In: Massaro E, Rogers JM (eds) Symposium on folates and human development. Humana Press, New York, pp 117–135
Kamen BA, Caston JD (1975a) Identification of a folate binder in hog kidney. J Biol Chem 250:2203–2205
Kamen BA, Caston JD (1975b) Purification of a folate binding factor in normal human umbilical cord serum. Proc Natl Acad Sci USA 72:4261–4264
Kamen BA, Caston JD (1986) Properties of a folate binding protein (FBP) isolated from porcine kidney. Biochem Pharmacol 35:2323–2329
Kamen BA, Smith AK (2004) A review of folate receptor alpha cycling and 5-methyltetra-hydrofolate accumulation with an emphasis on cell models in vitro. Adv Drug Deliv Rev 56:1085–1097
Kamen BA, Wang MT, Streckfuss AJ, Peryea X, Anderson RGW (1988) Delivery of folates to the cytoplasm of MA104 cells is mediated by a surface membrane receptor that recycles. J Biol Chem 263:13602–13609
Kinoshita T, Fujita M, Maeda Y (2008) Biosynthesis, remodeling and functions of mammalian GPI-anchored proteins: recent progress. J Biochem 144:287–294
Lark RH, Smith AS, Kamen BA (1996) Folylpolyglutamate synthetase but not folate receptor correlates with MA104 cell growth in vitro. Cancer Res Ther Control 5:1–10
Leamon CP, Jackman AL (2008) Exploitation of the folate receptor in the management of cancer and inflammatory disease. Vitam Horm 79:203–233
Lewis CM, Smith AK, Nguyen C, Kamen BA (1998a) PMA alters folate receptor distribution in the plasma membrane and increases the rate of 5-methyltetra-hydrofolate delivery in mature MA104 cells. Biochim Biophys Acta 1401:157–169
Lewis CM, Smith AK, Kamen BA (1998b) Cytochalasin D induced F-actin disruption increases receptor mediated folate delivery. Cancer Res 58:2592–2956
Matsue H, Rothberg KG, Takashima A, Kamen BA, Anderson RGW, Lacey SW (1992) Potocytosis of folate selects cells for growth in physiologic concentrations of the vitamin. Proc Nat Acad Sci USA 89:6006–6009
Matteson EL, Lowe VJ, Prendergast FG, Crowson CS, Moder KG, Morgenstern DE, Messmann RA, Low PS (2009) Assessment of disease activity in rheumatoid arthritis using a novel folate targeted radiopharmaceutical Folatescan. Clin Exp Rheumatol 27:253–259
McHugh M, Cheng YC (1979) Demonstration of a high affinity folate binder in human cell membranes and its characterization in cultured human KB cells. J Biol Chem 254:11312–11318
Miotti S, Bagnoli M, Tomassetti A, Colnaghi MI, Canevari S (2000) Interaction of folate receptor with signaling molecules lyn and G(alpha)(i-3) in detergent-resistant complexes from the ovary carcinoma cell line IGROV1. J Cell Sci 113(Pt 2):349–357
Molloy AM, Quadros EV, Sequeira JM, Troendle JF, Scott JM, Kirke PN, Mills JL (2009) Lack of association between folate-receptor autoantibodies and neural-tube defects. N Engl J Med 36:152–160
Orr R, Kamen BA (1995) Mutant folate receptors exhibit a dominant negative effect when transfected into cells with wt receptor. Cancer Res 55:847–852
Orr R, Kreisler AR, Kamen BA (1995) Similarity of folate receptor expression in UMSCC 38 cells to squamous cell carcinoma differentiation markers. J Natl Cancer Inst 87:299–303
Pisano MM, Bhattacherjee V, Wong L, Finnell RH, Greene RM (2010) Novel folate binding protein-1 interactions in embryonic orofacial tissue. Life Sci 86:275–280
Puig-Kröger A, Sierra-Filardi E, Domínguez-Soto A, Samaniego R, Corcuera MT, Gómez-Aguado F, Ratnam M, Sánchez-Mateos P, Corbí AL (2009) Folate receptor beta is expressed by tumor-associated macrophages and constitutes a marker for M2 anti-inflammatory/regulatory macrophages. Cancer Res 69:9395–9403
Ramaekers VT, Blau N, Sequeira JM, Nassogne MC, Quadros EV (2007a) Folate receptor autoimmunity and cerebral folate deficiency in low-functioning autism with neurological deficits. Neuropediatrics 38:276–281
Ramaekers VT, Sequeira JM, Artuch R, Blau N, Temudo T, Ormazabal A, Pineda M, Aracil A, Roelens F, Laccone F, Quadros EV (2007b) Folate receptor autoantibodies and spinal fluid 5-methyltetrahydrofolate deficiency in Rett syndrome. Neuropediatrics 38:179–183
Rothberg KG, Ying Y, Kolhouse JF, Kamen BA, Anderson RGW (1990) The glycophospholipid linked folate receptor recycles without entering the clathrin coated pit endocytic pathway. J Cell Biol 110:637–649
Rothenberg SP (1970) A macromolecular factor in some leukemic cells which binds folic acid. Proc Soc Exp Biol Med 133:428–432
Rothenberg SP, Frances G, Kamen BA (1969) Antibodies against folic acid – I. In vitro biophysical effect. J Lab Clin Med 74:622–671
Salter DN, Ford JE, Scott KJ, Andrews P (1972) Isolation of the folate-binding protein from cow’s milk by the use of affinity chromatography. FEBS Lett 20:302–306
Shih Ie-M, Davidson B (2009) Pathogenesis of ovarian cancer: clues from selected overexpressed genes. Future Oncol 5:1641–1657
Spector R (1977) Identification of folate binding macromolecule in rabbit choroid plexus. J Biol Chem 252:3364–3370
Spiegelstein O, Eudy JD, Finnell RH (2000) Identification of two putative novel folate receptor genes in humans and mouse. Gene 258:117–125
Steinfeld R, Grapp M, Kraetzner R, Dreha-Kulaczewski S, Helms G, Dechent P, Wevers R, Grosso S, Gärtner J (2009) Folate receptor alpha defect causes cerebral folate transport deficiency: a treatable neurodegenerative disorder associated with disturbed myelin metabolism. Am J Hum Genet 85:354–363
Suleiman SA, Spector R, Cancilla P (1981) Partial purification and characterization of a folate-binding protein from human choroid plexus. Neurochem Res 6:333–341
Weitman S, Anderson RGW, Kamen BA (1994) Folate binding proteins. In: Dakshinamurti K (ed) Vitamin receptors: vitamins as ligands in cell communication. Cambridge University Press, Cambridge, pp 103–136
Wevers RA, Hansen SI, van Hellenberg Hubar JL, Holm J, Høier-Madsen M, Jongen PJ (1994) Folate deficiency in cerebrospinal fluid associated with a defect in folate binding protein in the central nervous system. J Neurol Neurosurg Psychiatry 57:223–226
Willis SA, Lacey SW, Weitman SD, Kamen BA, Nisen PD (1992) Folate receptor gene expression is tissue-specific and temporally-regulated. Cancer Ther Control 2:223–230
Wollack JB, Makori B, Ahlawat S, Koneru R, Picinich SC, Smith A, Goldman ID, Qiu A, Cole PD, Glod J, Kamen B (2008) Characterization of folate uptake by choroid plexus epithelial cells in a rat primary culture model. J Neurochem 104:1494–1503
Yamaguchi T, Hirota K, Nagahama K, Ohkawa K, Takahashi T, Nomura T, Sakaguchi S (2007) Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor. Immunity 27:145–159
Yao C, Evans CO, Stevens VL, Owens TR, Oyesiku NM (2009) Folate receptor alpha regulates cell proliferation in mouse gonadotroph alphaT3-1 cells. Exp Cell Res 315:3125–3132
Zhao R, Min SH, Wang Y, Campanella E, Low PS, Goldman ID (2009) A role for the proton-coupled folate transporter (PCFT-SLC46A1) in folate receptor-mediated endocytosis. J Biol Chem 284:4267–4274
Acknowledgments
In the course of more than 40 years since I have done folate receptor (FR)/folate binding protein research, I have had the privilege of meeting with, collaborating with, and simply talking to an outstanding group of basic and clinical investigators especially as the folate binding protein “morphed” into the FR both in the field of basic biology and also the application of the receptor as a target for therapeutics has developed. Many of these people are contributors to this text. There are more than 1,300 citations in PubMed for “folate receptor” covering basic biology and the medical application of the family of FRs. Justice could not be done to all in a short chapter, so to everyone, I simply say thank you.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Kamen, B.A. (2011). Folate Receptors and Therapeutic Applications. In: Jackman, A., Leamon, C. (eds) Targeted Drug Strategies for Cancer and Inflammation. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-8417-3_2
Download citation
DOI: https://doi.org/10.1007/978-1-4419-8417-3_2
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-8416-6
Online ISBN: 978-1-4419-8417-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)